Passive Q-switching or mode-locking by placing a saturable absorber inside the laser cavity is one of the most effective and popular techniques for pulse generation. However, most of the current saturable absorbers cannot work well in the visible spectral region, which seriously impedes the progress of passively Q-switched/mode-locked visible pulsed fibre lasers. Here, we report a kind of visible saturable absorber-two-dimensional transition-metal dichalcogenides (TMDs, e.g. WS2, MoS2, MoSe2), and successfully demonstrate compact red-light Q-switched praseodymium (Pr(3+))-doped all-fibre lasers. The passive Q-switching operation at 635 nm generates stable laser pulses with ∼200 ns pulse duration, 28.7 nJ pulse energy and repetition rate from 232 to 512 kHz. This achievement is attributed to the ultrafast saturable absorption of these layered TMDs in the visible region, as well as the compact and all-fibre laser-cavity design by coating a dielectric mirror on the fibre end facet. This work may open a new route for next-generation high-performance pulsed laser sources in the visible (even ultraviolet) range.
BackgroundLittle has been known about the role of non-coding RNA regulatory network in the patterns of growth and invasiveness of gastric cancer (GC) development.MethodsMicroRNAs (miRNAs) microarray was used to screen differential miRNA expression profiles in Ming’s classification. The significant differential expressions of representative miRNAs and their interacting circular RNA (circRNA) were confirmed in GC cell line and 63 pairs of GC samples. Then, a circRNA/miRNA network was constructed by bioinformatics approaches to identify molecular pathways. Finally, we explored the clinical value of the common targets in the pathway by using receiver operating characteristic curve and survival analysis.ResultsSignificantly differential expressed miRNAs were found in two pathological types of GC. Both of miR-124 and miR-29b were consistently down-regulated in GC. CircHIPK3 could play a negative regulatory role on miR-124/miR-29b expression and associated with T stage and Ming’s classification in GC. The bioinformatics analyses showed that targets expression of circHIPK3-miR-124/miR-29b axes in cancer-related pathways was able to predict the status of GC and associated with individual survival time.ConclusionsThe targets of circHIPK3-miR-124/miR-29b axes involved in the progression of GC. CircHIPK3 could take part in the proliferation process of GC cell and may be potential biomarker in histological classification of GC.Electronic supplementary materialThe online version of this article (10.1186/s12967-018-1582-8) contains supplementary material, which is available to authorized users.
This paper reports co-crystallization of two atomically precise, different-size ligand-stabilized nanoclusters, a spherical (AuAg)267(SR)80 and a smaller trigonal-prismatic (AuAg)45(SR)27(PPh3)6 in 1:1 ratio, characterized fully by X-ray crystallographic analysis (SR = 2,4-SPhMe2). The larger cluster has a four concentric-shell icosahedral structure of Ag@M12@M42@M92@Ag120(SR)80 (M = Au or Ag) with the inner-core M147 icosahedron observed here for metal nanoparticles. The cluster has an open electron shell of 187 delocalized electrons, fully metallic, plasmonic behavior, and a zero HOMO-LUMO energy gap. The smaller cluster has an 18-electron shell closing, a notable HOMO-LUMO energy gap and a molecule-like optical spectrum. This is the first direct demonstration of the simultaneous presence of competing effects (closing of atom vs. electron shells) in nanocluster synthesis and growth, working together to form a co-crystal of different-sized clusters. This observation suggests a strategy that may be helpful in the design of other nanocluster systems via co-crystallization.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.